1 / 29

The public benefits of health and medical research

The public benefits of health and medical research. Professor Warwick Anderson Chief Executive Officer. NHMRC Act amended 2006. Establishes NHMRC as an independent statutory agency within the health portfolio. To raise the standard of individual and public health throughout Australia

jess
Télécharger la présentation

The public benefits of health and medical research

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The public benefits of health and medical research Professor Warwick Anderson Chief Executive Officer

  2. NHMRC Act amended 2006 Establishes NHMRC as an independent statutory agency within the health portfolio • To raise the standard of individual and public health throughout Australia • To foster the development of consistent health standards between the various States and Territories • To foster medical research and training and public health research and training throughout Australia; and • To foster consideration of ethical issues relating to health NHMRC’s Strategic Plan - Parliament Must contain “the CEO’s assessment of the major national health issues that are likely to arise during the period (of the Strategic Plan)”.

  3. “Highways to Health” IMPROVED INDIVDUAL AND COMMUNITY HEALTH PROSPERITY Improving health globally and regionally Prevention New treatments, therapies Improved delivery of primary, hospital health care Innovative industry development KNOWLEDGE RESEARCH

  4. NHMRC Funding Schemes - Summary • Support for health and medical Research – • Program Grants • Project Grants • Development awards • Building Australia's Research capacity • People: • Fellowships • Career Development Awards • Training Fellowships • Scholarships • Fields • Capacity Building Grants in Population health Research • Capacity Building Grants in Health services Research • Centres of Clinical Research Excellence • Research Infrastructure: • Infrastructure Grants for Independent Medical Research Institutes • Enabling Grants • Equipment Grants

  5. Grants for support of research Grant $ Number Program Grants $103,319,442 65 Project Grants $281,747,558 1719 Development Grants $3,084,852 36 Priority & Strategic Grants $7,471,287 25

  6. NHMRC Project GrantsMore could be funded Not recommended for funding (score <4) Fundable, but not funded (score ≥4) Funded

  7. Where the Funding GoesAdministering Institution NHMRC research expenditure in 2007

  8. NHMRC Funding to all Universities (2000 and 2007)

  9. NHMRC Funding of top 10 Institutions - 2008 Top 10 = 66.9% of total funds

  10. Where the Funding Goes Percentage of NHMRC research expenditure to each state and territory 2000 – 2007

  11. “Highways to Health” IMPROVED INDIVDUAL AND COMMUNITY HEALTH PROSPERITY Improving health globally and regionally Prevention New treatments, therapies Improved delivery of primary, hospital health care Innovative industry development KNOWLEDGE RESEARCH

  12. National Health Priority Areas (NHPA)

  13. Aboriginal & Torres Strait Islander Research • NHMRC has a target of allocating 5% of the Medical Research Endowment Account (MREA) to Aboriginal and Torres Strait Islander related research

  14. NHMRC Funding for Indigenous Health Funding (2000-2007)

  15. Intellectual Property Patents in NHMRC project grant applications (2000 – 2006)

  16. A Study of NHMRC final reports The following slides are an analysis of data received on final reports from NHMRC funded grants. This includes: • 1208 final reports from grants that ended in 2003, 2004 and 2005 • With a total value of $460.1 million of NHMRC funding between 1998 and 2005. • Scholarships, equipment grants and block funding are excluded.

  17. Intellectual Property Has this research award resulted in the development of Intellectual Property? Yes 227 19% No 953 79% Not Answered 28 2% Total 1208 100%

  18. Commercialisation Reported commercial actions arising out of the research includes 29 start up companies, 11 reports of sales of products, and 3 IPO listings.

  19. Leverage of National and International funds Total investment of $460.1 million for 1208 NHMRC grants resulted in leveraged funds of $254.4 million from; • National sources: $124.1 million • International sources: $130.3 million

  20. $US31.1 million (10% of total NIH international investment) Leverage of National and International funds

  21. New policy and practice focusedresearch: NHMRC Partnerships • NHMRC Partnerships will focus on informing both policy and practice in • health. This represents a new focus for the NHMRC in 2008. • The initiative will: • help create partnerships between policy makers, managers, clinicians and researchers • provide funding and support to create new opportunities for researchers and • policy makers to work together • The aims are to: • Lead to more effective connections between policy makers and researchers • Improve the availability and quality of research evidence to inform policy • Process • NHMRC Partnerships will initially fund two types of awards • NHMRC Partnership Projects (ARC Linkage -like) • NHMRC Partnerships Centres for Research excellence

  22. 2005 Nobel Prize WinnersProfessor Barry MarshallProfessor Robin Warren University of Western Australia Marshall and Warren shared the Nobel Prize in Physiology or Medicine for their discovery of the Helicobacter pylori and its role in gastritis and peptic ulcer disease.

  23. 1996 Nobel Prize WinnerProfessor Peter Doherty John Curtin School of Medical Research Professor Doherty received the Nobel Prize for his milestone research into cellular immunology and discovery of how the body's immune system recognises virus-infected cells.

  24. 2006 Australian of the YearProfessor Ian Frazer University of Queensland Honoured as “Australian of the Year” for his groundbreaking work on the development of a vaccine for cervical cancer.His work will prevent a virus that leads to half a million cases of cancer in women around the world each year, and takes hundreds of thousands of lives.

  25. Commercial outcomes NHMRC support : Development Grants (under review) Support Enhancement Options Australian success stories: Cochlear - Total revenue for the year 2006 increased 30% to a record $452.3 million ResMed - Delivered a record financial performance achieving $607 million in revenues, an increase of 43% from 2005 CSL (now with Gardasil!) - Consolidated Group profit for 2007 $539.3 million

  26. Water Fluoridation • Australia’s main public health strategy in reducing the prevalence of dental caries. • NHMRC has funded evaluative research since the 1980s (validating the safety, optimal levels and cost-effectiveness of water fluoridation) • For each $1 invested in water fluoridation, estimated savings in dental treatment range from $12.60 to $80.00, with the greatest benefit to the most disadvantaged. • NHMRC supported research has: • informed public debate, • provided an objective view on costs and benefits, and • provided reports that enable politically challenging policy decisions. Source: Access Economics, draft Report – Returns to NHMRC funded R&D (2008)

  27. Venous Thromboembolism • It is estimated that, in 2008, there will be: • 14,700 hospitalisations • 5,285 deaths • VET costs $116,970 per case due to lost productivity from premature death. • Health system expenditure is $10,007 per case. • NICS developed and implemented the Stop the Clotcampaign. • Savings from the NHMRC component alone would be 5 lives per annum and $1.6 million in savings to the health system. Source: Access Economics, draft Report – Returns to NHMRC funded R&D (2008)

  28. NHMRC Working to build a healthy Australia www.nhmrc.gov.au

  29. CSL - Gardasil • A vaccine against certain types of human papillomavirus. • Royalties attribution yields a benefit of $63 million per annum to Australia. • Potential benefits include the saving of 225,000 lives each year worldwide. • CSL Consolidated Group profit for 2007 = $539.3 million Source: Access Economics, draft Report – Returns to NHMRC funded R&D (2008)

More Related